The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms

Movement Disorders

Volumn 23, Issue 2, 2008, Pages 190-194

  Pellecchia, Maria Teresa ^a   Longo, Katia ^a   Manfredi, Michela ^b   Lucetti, Claudio ^c   Cossu, Giovanni ^d   Petrone, Alfredo ^e   Marconi, Roberto ^f   Sensi, Mariachiara ^g   Epifanio, Antonio ^h   Eleopra, Roberto ⁱ   Marchese, Roberta ^j   Scaravilli, Tomaso ^k   Morgante, Letterio ^h   Abbruzzese, Giovanni ^j   Bonuccelli, Ubaldo ^c   Donati, Edoardo ^b   Pivonello, Rosario ^a   Colao, Annamaria ^a   Barone, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Poliambulanza Hospital   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d Neurology Unit General Hospital S Michele AOB Brotzu   (Italy)

^e ANNUNZIATA HOSPITAL   (Italy)

^f MISERICORDIA HOSPITAL   (Italy)

^g UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^h UNIVERSITY OF MESSINA   (Italy)

ⁱ Umberto I Hospital   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k UNIVERSITY OF PADOVA   (Italy)

more..

Author keywords

Arginine test; Growth hormone; Multiple system atrophy; Progressive supranuclear palsy

Indexed keywords

ARGININE; GROWTH HORMONE;

AGED; ANALYSIS OF VARIANCE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROVOCATION TEST; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHY DRAGER SYNDROME; STATISTICAL SIGNIFICANCE;

AGED; ANALYSIS OF VARIANCE; ARGININE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PARKINSONIAN DISORDERS; ROC CURVE;

EID: 39749188103     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21700     Document Type: Article

References (25)

1. Hughes AJ, Daniel SE, Ben Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
2. Hughes AI, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181- 184.
3. Pellecchia MT, Longo K, Pivonello R, et al. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test. Ann Neurol 2006;60: 611-615.
4. Warren NM, Piggot EK, Perry EK, Burn DJ. Cholinergic systems in progressive supranuclear palsy. Brain 2005;128:239-249.
5. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst 1998;74: 189-192.
6. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson- Olszewski): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
7. Gibb WR, Lees AJ. The relevance of the Lewy body in the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
8. Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiol Rev 1999;79:511-607.
9. The Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004;351:2498-2508.
10. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
11. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19:717-797.
12. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency. J Clin Endocrinol Metab 1998;83:379-381.
13. Alba-Roth J, Muller OA, Schopol J, et al. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metabol 1988;1186-1189.
14. Kimber JR, Watson L, Mathias CG. Distinction of idiopathic Parkinson's disease from multiple system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997;349:1877- 1881.
15. Clarke CR, Ray PS, Speller JM. Failure of the clonidine growthhormone stimulation test to differentiate multiple-system atrophy from early or advanced idiopathic Parkinson's disease. Lancet 1999;353:1329-1330.
16. Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, et al. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease? J Neurol 2000;415:853-856.
17. Strijks E, van't Hof M, Sweep F, et al. Stimulation of growthhormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. J Neurol 2002;249:1206-1210.
18. Lee EAH, Joon KB, Lee WY. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography. Mov Disord 2002;17:1242-1247.
19. Kimber J, Mathias CJ, Lees AJ, et al. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy. Brain 2000;123:1422-1430.
20. Tago H, McGeer PL, Bruce G, et al. Distribution of choline acetyltransferase-containing neurons of the hypothalamus. Brain Res 1987;415:49-62.
21. Caffè AR. Architecture of the mammalian pituitary cholinergic system with observations on a putative blood acetylcholine sensor. Histol Histopathol 1996;11:537-551.
22. Spokes EGS, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure. J Neurol Sci 1979;43:59-82.
23. Norbiato G, Bevilacqua M, Righini V, et al. Altered vasopressin response to metoclopramide in multiple system atrophy: evidence of a cholinergic defect in the hypothalmus. Acta Neurol Scand 1992;85:299-301.
24. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002;59:944-946.
25. Kida M, Koo H, Grossniklaus HE, Tomsak RL. Neuropathological findings in progressive supranuclear palsy. A brief review with two additional case reports. J Clin Neuroophtalmol 1988;8:161-170.